These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26771114)

  • 1. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
    Mardinoglu A; Boren J; Smith U
    Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus.
    Holmes D
    Nat Rev Endocrinol; 2016 Feb; 12(2):61. PubMed ID: 26668122
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin Joins Forces with Microbes.
    Cabreiro F
    Cell Host Microbe; 2016 Jan; 19(1):1-3. PubMed ID: 26764588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and gut microbiota: their interactions and their impact on diabetes.
    Vallianou NG; Stratigou T; Tsagarakis S
    Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICROBIOME. Prescription drugs obscure microbiome analyses.
    Devkota S
    Science; 2016 Jan; 351(6272):452-3. PubMed ID: 26823414
    [No Abstract]   [Full Text] [Related]  

  • 8. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.
    Van Syoc E; Nixon MP; Silverman JD; Luo Y; Gonzalez FJ; Elbere I; Klovins J; Patterson AD; Rogers CJ; Ganda E
    mBio; 2024 Jun; 15(6):e0016924. PubMed ID: 38767350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin: old friend, new ways of action-implication of the gut microbiome?
    Rodriguez J; Hiel S; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
    Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
    Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
    Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
    Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.
    Rosell-Díaz M; Petit-Gay A; Molas-Prat C; Gallardo-Nuell L; Ramió-Torrentà L; Garre-Olmo J; Pérez-Brocal V; Moya A; Jové M; Pamplona R; Puig J; Ramos R; Bäckhed F; Mayneris-Perxachs J; Fernández-Real JM
    Metabolism; 2024 Aug; 157():155941. PubMed ID: 38871078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
    Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
    Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
    Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
    PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
    Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
    Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.